RJFSA
JNCE

Raymond James Financial Services Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,427
Closed -$101K – 3051
2020
Q3 		$101K Sell
12,427
-5,202
-30% -$42.3K ﹤0.01% 2681
2020
Q2 		$122K Buy
+17,629
New +$122K ﹤0.01% 2592